To include your compound in the COVID-19 Resource Center, submit it here.
TECHNOLOGY: Tissue markers
Tumor levels of SMARCA2 RNA could help predict responses to EZH2 inhibitors in cancers harboring mutations in the SWI/SNF complex. In
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury